Oppenheimer Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $19
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Mitchel Penn maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20 to $19.
Oppenheimer analyst Mitchel Penn maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20 to $19.